---
title: "Venmax Drugs & Pharmaceuticals Ltd (531015) — Share Price, Financials & Analysis"
symbol: "531015"
company: "Venmax Drugs & Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/531015"
isin: "INE154G01022"
nse_symbol: "VENMAXDRUGSPHARMACEUTICALSLTD"
bse_code: "531015"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 22.64
generated_at: "2026-09-13T18:34:50.428Z"
---

# Venmax Drugs & Pharmaceuticals Ltd (531015)

Canonical page: https://tapetide.com/stocks/531015

## Company

- **NSE Symbol:** VENMAXDRUGSPHARMACEUTICALSLTD
- **BSE Code:** 531015
- **ISIN:** INE154G01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** venmaxdrugs.com

## About

Incorporated in 1998, Venmax Drugs & Pharmaceuticals Ltd is engaged in the business of IT & ITES services[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:42:26.657303Z.

- **Market Cap:** ₹22.64 Cr
- **Classification:** Microcap
- **P/E (reported):** 76.9
- **EPS (TTM):** ₹0.25
- **Book Value:** ₹14.37
- **Price to Book:** 1.02
- **Dividend Yield:** 0%
- **ROE:** 1.76%
- **ROCE:** 1.96%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹8.2 Cr
- **Net Income:** ₹0.2 Cr
- **EBITDA:** ₹0.3 Cr
- **52-Week High:** ₹31.49
- **52-Week Low:** ₹13.52
- **RSI (14):** 45.28

## Tapetide Score

- **Score:** 36 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 7.3 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 82.51 | 9% |
| growth | 98.9 | 9% |
| momentum | 6.42 | 12% |
| ownership | 36.41 | 24% |
| quality | 21.32 | 22% |
| valuation | 23.74 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 1.17 times its book value
- Debtor days have improved from 247 to 65.1 days.

### Weaknesses

- Promoter holding has decreased over last quarter: -3.34%
- Promoter holding is low: 10.5%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -380.35% | -11% | -675.92% |
| ebitda margin growth | 0% | -936.59% | -92.76% | -96.33% |
| net income growth | 0% | — | 3% | 29% |
| revenue growth | -37.5% | 331.58% | 244.82% | 116% |
| roce | — | -712.5% | -114.56% | -48.2% |
| roe | — | -833.33% | -2.8% | -100.9% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0.1 | 0.17 | 0.2 | 0.33 | 1.21 | 1.32 | 1.55 | 3.94 | 2.48 |
| Expenses | 0.03 | 0.01 | 0.04 | 0.12 | 0.47 | 0.69 | 0.57 | 1.17 | 1.27 | 1.58 | 3.92 | 2.36 |
| Operating Profit | -0.03 | -0.01 | -0.04 | -0.02 | -0.3 | -0.49 | -0.24 | 0.04 | 0.05 | -0.03 | 0.02 | 0.12 |
| OPM % | — | — | — | -20 | -176.47 | -245 | -72.73 | 3.31 | 3.79 | -1.94 | 0.51 | 4.84 |
| Other Income | 0 | 0.05 | 0.1 | 0.03 | 0 | 0 | 1.02 | 0 | 0 | 0.07 | 0.09 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.03 | 0.04 | 0.06 | 0.01 | -0.3 | -0.49 | 0.78 | 0.04 | 0.05 | 0.04 | 0.11 | 0.12 |
| Tax % | 0 | 25 | 16.67 | 0 | 0 | 0 | 0 | 0 | 40 | 25 | 0 | 0 |
| Net Profit | -0.03 | 0.03 | 0.05 | 0.01 | -0.3 | -0.5 | 0.78 | 0.04 | 0.02 | 0.03 | 0.11 | 0.12 |
| EPS in Rs | -0.06 | 0.06 | 0.1 | 0.02 | -0.57 | -0.95 | 1.49 | 0.08 | 0.02 | 0.04 | 0.09 | 0.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0.15 | 0.47 | 0.17 | 0 | 0 | 0 | 0.81 | 8.02 | 9.29 |
| Expenses | 0.23 | 0.38 | 0.72 | 0.5 | 0.12 | 0.19 | 0.11 | 1.87 | 7.9 | 9.13 |
| Operating Profit | -0.23 | -0.23 | -0.25 | -0.33 | -0.12 | -0.19 | -0.11 | -1.06 | 0.12 | 0.16 |
| OPM % | — | -153.33 | -53.19 | -194.12 | — | — | — | -130.86 | 1.5 | 1.72 |
| Other Income | 0 | 0 | 0 | 0.18 | 1.98 | 0.42 | 0.2 | 1.05 | 0.16 | 0.16 |
| Interest | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| Profit before tax | -0.24 | -0.24 | -0.26 | -0.16 | 1.85 | 0.22 | 0.08 | -0.02 | 0.28 | 0.32 |
| Tax % | 0 | 0 | 3.85 | 0 | 0 | 0 | 25 | 0 | 10.71 | — |
| Net Profit | -0.24 | -0.24 | -0.27 | -0.16 | 1.85 | 0.23 | 0.06 | -0.01 | 0.25 | 0.28 |
| EPS in Rs | -0.46 | -0.46 | -0.52 | -0.31 | 3.53 | 0.44 | 0.11 | -0.02 | 0.22 | 0.25 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 | 11.58 |
| Reserves | -7.11 | -7.35 | -7.59 | -7.86 | -8.03 | -6.18 | -5.95 | -5.89 | -0.83 | 2.53 |
| Borrowings | 1.85 | 2.04 | 2.24 | 2.52 | 2.33 | 0.35 | 0.35 | 0.35 | 0.05 | 0.33 |
| Other Liabilities | 0.16 | 0.14 | 0.44 | 0.56 | 0.76 | 0.8 | 0.57 | 0.38 | 0.71 | 1.76 |
| Total Liabilities | 0.14 | 0.07 | 0.33 | 0.46 | 0.3 | 0.21 | 0.21 | 0.08 | 5.17 | 16.2 |
| Fixed Assets | 0 | 0 | 0.11 | 0.1 | 0.09 | 0.08 | 0.07 | 0.07 | 0.04 | 0.04 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.14 | 0.07 | 0.22 | 0.36 | 0.21 | 0.13 | 0.14 | 0.01 | 5.13 | 16.16 |
| Total Assets | 0.14 | 0.07 | 0.33 | 0.46 | 0.3 | 0.21 | 0.21 | 0.08 | 5.17 | 16.2 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1.06 | -0.26 | -0.05 | -0.28 | 0.26 | 1.91 | 0 | 0 | -2.29 | -11 |
| Cash from Investing Activity | 0.01 | 0 | -0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 1.02 | 0.26 | 0.16 | 0.28 | -0.19 | -1.98 | 0 | 0 | 4.77 | 9.74 |
| Net Cash Flow | -0.03 | 0 | 0 | 0 | 0.07 | -0.07 | 0 | 0 | 2.48 | -1.26 |
| Free Cash Flow | -1.05 | -0.26 | -0.17 | -0.28 | 0.26 | 1.91 | 0 | 0 | -2.29 | -11 |
| CFO/OP | 171 | 113 | 22 | 112 | -79 | -1592 | 0 | -18 | 216 | -9142 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | — | 0 | 31.06 | 85.88 | — | — | — | 428.09 | 65.08 |
| Inventory Days | 0 | — | 446.11 | 250.94 | 0 | — | — | — | 27.72 | 50.14 |
| Days Payable | — | — | 1257.22 | 456.25 | — | — | — | — | 291.08 | 84.23 |
| Cash Conversion Cycle | 0 | — | -811.11 | -174.25 | 85.88 | — | — | — | 164.73 | 30.99 |
| Working Capital Days | -2723.46 | — | -5986 | -2112.34 | -6333.82 | — | — | — | 874.2 | 587.55 |
| ROCE % | -52.63 | — | — | — | — | — | — | — | -0.96 | 2.96 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 23.14% | 23.14% | 23.14% | 23.14% | 23.14% | 23.14% | 23.14% | 23.14% | 23.14% | 15.14% | 13.8% | 10.46% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0.15% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 65.66% | 65.66% | 65.66% | 65.66% | 65.67% | 65.54% | 65.24% | 65.01% | 65.36% | 64.25% | 66.29% | 74.34% |
| Others | 11.06% | 11.06% | 11.06% | 11.06% | 11.04% | 11.17% | 11.47% | 11.86% | 11.51% | 20.61% | 19.91% | 15.2% |
| No. of Shareholders | 6250 | 6252 | 6251 | 6252 | 6291 | 6657 | 6756 | 6729 | 6764 | 6815 | 6802 | 6865 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 6 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 14.8 | Buy |
| EMA (10) | 14.92 | Buy |
| SMA (20) | 15.38 | Sell |
| EMA (20) | 15.38 | Sell |
| SMA (50) | 16.65 | Sell |
| EMA (50) | 16.78 | Sell |
| SMA (100) | 19.5 | Sell |
| EMA (100) | 18.86 | Sell |
| SMA (200) | 22.85 | Sell |
| EMA (200) | 21.36 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.85 | Neutral |
| MACD (12,26,9) | -0.65 | Buy |
| Stochastic (14,3,3) | 37.48 | Neutral |
| ADX (14) | 15.34 | Neutral |
| Williams %R (14) | -43.62 | Neutral |
| ATR (14) | 1.74 | High Volatility |
| ROC (12) | 4.32 | Buy |
| Stoch RSI (14) | 97.69 | Sell |
| UO (7,14,28) | 44.4 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e4e3ff8-a3c3-43e7-8ed6-4090ccf7ffee.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c0de31f-c322-4a03-8257-dc91f63993d6.pdf) |
| 2026-08-31 | [Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8dc56cde-b8ad-4a40-90ff-85701f3cb953.pdf) |
| 2026-08-24 | [Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edb00666-2faf-4100-8aac-7cc2d4125ddf.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8c10edf-dc16-46fd-baff-f4b991e3d058.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de13e463-b8ca-4b99-9062-2b19804f5262.pdf) |
| 2026-08-07 | [Statement Of Deviation & Variation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b53f03-53f3-4d16-988c-e3eb783c94ed.pdf) |
| 2026-08-01 | [Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32c06f4b-ef99-4ffc-b014-dda0732e436f.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=770fcaa1-f0a7-45a9-a275-2e03374b676e.pdf) |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ff7ae65-0976-4304-a83a-72713f28384b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbc72980-1f14-4d95-852c-c6682f4f90e2.pdf) |
| 2026-05-14 | [Audited Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1643fe1d-c646-43cd-ad33-eabd06d8f99b.pdf) |
| 2026-02-07 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca997428-6c18-4396-be92-6767a9ea6369.pdf) |
| 2025-11-12 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05ebd949-4fe8-434b-ad0e-6d898256a0c5.pdf) |
| 2025-07-23 | [Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8131dbca-423a-40d4-9ac8-11b16e3b3fcc.pdf) |
| 2025-05-09 | [Audited Financial Results March 31St 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=483bd003-1e86-4469-881c-78d0e3bbcd93.pdf) |
| 2024-09-16 | [Refiling Of Financial Results For The Quarter And Year Ended 31.03.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=208d2b8a-9a6d-4314-a420-d620609a9740.pdf) |
| 2024-01-30 | [Financial Results For The Quarter Ended December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe80d312-f8ad-466f-8e27-bbe7f36f70d4.pdf) |
| 2023-05-15 | [Board Meeting Outcome for Audited Financial Results For The Quarter (Q4) And Year Ended 31St March, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08e8a118-790f-46ae-9c55-71044052b1b7.pdf) |
| 2023-01-30 | [Board Meeting Outcome for Results For The Quarter (Q3) And Nine Months Ended December 31, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a957e293-ed04-45df-b30b-712a43d16893.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Newspaper Publication of unaudited financial results for the quarter and nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Feb - Newspaper Publication of unaudited financial results for the quarter and nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a6e0c36-4d33-4b93-ba50-e87253336205.pdf) |
| 7 Feb - Q3/9M FY26 results (31-Dec-2025): quarter revenue Rs162.06L, profit Rs3.21L; 27.69L warrants converted. | [Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. 7 Feb - Q3/9M FY26 results (31-Dec-2025): quarter revenue Rs162.06L, profit Rs3.21L; 27.69L warrants converted.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2219210d-10df-469f-9709-f375ac9919ad.pdf) |
| 7 Feb - No deviation in Rs.20.05 crore preferential issue proceeds; Rs9.99 crore received; Rs3.79cr working capital, Rs0.19cr corporate used. | [Statement Of Deviation And Variation For The Quarter Ended December 31, 2025. 7 Feb - No deviation in Rs.20.05 crore preferential issue proceeds; Rs9.99 crore received; Rs3.79cr working capital, Rs0.19cr corporate used.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cf9b63c-e7ed-4f29-88a2-dd6749783558.pdf) |
| 6 May - Board meeting on May 14, 2026 to approve audited FY26 financial results; trading window closed till May 16. | [Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026. 6 May - Board meeting on May 14, 2026 to approve audited FY26 financial results; trading window closed till May 16.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2037a69d-f8f2-4c58-b24c-089e27d6deb1.pdf) |
| 6 Apr - Promoters confirmed no encumbrance on their shares for FY2026 under SEBI SAST. | [Regulation 31(4) - SAST Disclosure 6 Apr - Promoters confirmed no encumbrance on their shares for FY2026 under SEBI SAST.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c70946c-65fe-4eb9-9940-7872784c6004.pdf) |
| 5 Feb - Newspaper Clippings of Postal Ballot Notice | [Announcement under Regulation 30 (LODR)-Newspaper Publication 5 Feb - Newspaper Clippings of Postal Ballot Notice](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5efbf91-a405-498f-9412-2b6795b4869b.pdf) |
| 30 Mar - Appointed Padmaja Sadhanala as additional non-exec director; Revoor Ramachandra as independent director for five years, effective March 30, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 30 Mar - Appointed Padmaja Sadhanala as additional non-exec director; Revoor Ramachandra as independent director for five years, effective March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cb40bb04-e843-4d21-819e-42d232a41455.pdf) |
| 30 Jan - Hester Biosciences posts audio recording of earnings call for quarter and nine months ended 31 Dec 2025. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan - Hester Biosciences posts audio recording of earnings call for quarter and nine months ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0fcebbc3-afee-4d9e-9592-25859f0662e4.pdf) |
| 30 Jan - Board meeting on Feb 7, 2026 to approve Q3/9M unaudited results; trading window closed till Feb 7. | [Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025. 30 Jan - Board meeting on Feb 7, 2026 to approve Q3/9M unaudited results; trading window closed till Feb 7.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/52e5458c-4056-4cef-897a-78429bb498d7.pdf) |
| 27 Mar - Board approved amended amalgamation (Mar 27, 2026): issued capital now 1,15,82,930 shares; paid-up Rs.11,58,29,300. | [Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation 27 Mar - Board approved amended amalgamation (Mar 27, 2026): issued capital now 1,15,82,930 shares; paid-up Rs.11,58,29,300.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9bbc58e7-a81c-4933-8eea-7960a1d0184c.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40c0fe69-5d20-4b96-ae6c-881b2aa47bd6.pdf) |
| Oct 2018 | [Concall - Oct 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/10/84c8c9d4-490c-4de1-8d30-4a96e8b5143c.pdf) |
| Oct 2016 | [Concall - Oct 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=528FD5A9_B0FA_45D0_A6AA_A9BA27212CFB_105356.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8cec2d9-c3ff-46b7-823e-bf5c6ef0df3e.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db1d735b-cb8e-475c-ae54-b17058e14719.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a164b93-4364-4314-89b6-7927763cae43.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15ce413e-4ea6-415b-92ac-bb2f1b72fd48.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9eb50bb7-837a-41b5-b864-8064be6be734.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/36774fe9-45fe-44e8-84ea-0e6e225bd775.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/e82ffe26-5914-4460-80f8-54abe18013af.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5850666-32d9-45ce-8b67-a2af928214d2.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/134da25c-9b82-4ed1-aec2-3902975a683f.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cda3171-ca19-4c9c-b310-1ce8047a0ba0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f204d61a-9272-4151-9ad7-7e9d8766a2e3.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2ad84ad-8a59-4ed1-9971-2b1c75ba585b.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1ae24e4-cfc8-4196-92a6-f17a8ea08bff.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524669/73962524669.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531015/77242531015.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524669/69086524669_26_07_21.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531015/77239531015.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:34:50.428Z.